Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.005
+0.205 (11.39%)
Jun 6, 2025, 3:08 PM - Market open
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $669.54 million as of June 6, 2025. Its market cap has decreased by -76.88% in one year.
Market Cap
669.54M
Enterprise Value
318.46M
1-Year Change
-76.88%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since October 15, 2010, Iovance Biotherapeutics's market cap has increased from $79.00M to $669.54M, an increase of 747.52%. That is a compound annual growth rate of 15.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 601.10M | -73.35% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 69.79% |
| Dec 31, 2014 | 217.50M | 9.63% |
| Dec 31, 2013 | 198.40M | 1,053.49% |
| Dec 31, 2012 | 17.20M | -78.23% |
| Dec 30, 2011 | 79.00M | 5.05% |
| Dec 31, 2010 | 75.20M | -4.81% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 689.08B |
| Johnson & Johnson | 371.83B |
| AbbVie | 335.55B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 273.05B |
| Abbott Laboratories | 232.08B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |